ConductScience.org, home

Paper37814010

Targeting pancreatic cancer metabolic dependencies through glutamine antagonism.

Encarnación-Rosado J and 13 others. Nat Cancer, 2024. Cited by 124 papers, by iCite.

Cite this record

ConductScience Library. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Papers, record 37814010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37814010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism.
PubMed
Journal
Nat Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
124
iCite
Relative citation ratio, by iCite
14.92, provisional
iCite
Revised in PubMed
2025-04-17
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Encarnación-Rosado JJoel
2Sohn ASWAlbert S W
3Biancur DEDouglas E
4Lin EYElaine Y
5Osorio-Vasquez VVictoriahttps://orcid.org/0000-0001-7956-1633
6Rodrick TTori
7González-Baerga DDiana
8Zhao EEnde
9Yokoyama YYumi
10Simeone DMDiane Mhttps://orcid.org/0000-0001-5142-3087
11Jones DRDrew Rhttps://orcid.org/0000-0001-8732-9818
12Parker SJSeth J
13Wild RRobert
14Kimmelman ACAlec Chttps://orcid.org/0009-0002-9465-8411

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Antineoplastic AgentsMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Humans
Glutamine
Cell Line, Tumor
Enzyme Inhibitors

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016087NCI NIH HHSUnited StatesP30CA016087PubMed and NIHNIH RePORTER
R35 CA232124NCI NIH HHSUnited StatesR35CA232124PubMed and NIHNIH RePORTER
S10 OD021747NIH HHSUnited StatesS10OD021747PubMed and NIHNIH RePORTER
R01 CA251726NCI NIH HHSUnited StatesR01CA251726PubMed and NIHNIH RePORTER
P01 CA117969NCI NIH HHSUnited StatesP01CA117969PubMed and NIHNIH RePORTER
P01A1080192National Cancer Institute (NCI)PubMedPubMed
1R01CA251726-01A1NCI NIH HHSUnited StatesR01CA251726PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04471415Study to Investigate DRP-104 in Adults With Advanced Solid TumorsDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132510550Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer.J Exp Med2020https://conductscience.org/library/papers/32510550PubMed
217872411Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.Science2007https://conductscience.org/library/papers/17872411PubMed
336383674Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug.Sci Adv2022https://conductscience.org/library/papers/36383674PubMed
436973407Nucleotide metabolism: a pan-cancer metabolic dependency.Nat Rev Cancer2023https://conductscience.org/library/papers/36973407PubMed
531221965Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer.Nat Commun2019https://conductscience.org/library/papers/31221965PubMed
635930753Sirpiglenastat (DRP-104) Induces Antitumor Efficacy through Direct, Broad Antagonism of Glutamine Metabolism and Stimulation of the Innate and Adaptive Immune Systems.Mol Cancer Ther2022https://conductscience.org/library/papers/35930753PubMed
732393771Pancreatic cancer stroma: an update on therapeutic targeting strategies.Nat Rev Gastroenterol Hepatol2020https://conductscience.org/library/papers/32393771PubMed
816585505Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16585505PubMed
922101431Reductive carboxylation supports growth in tumour cells with defective mitochondria.Nature2011https://conductscience.org/library/papers/22101431PubMed
1036949199RHOJ controls EMT-associated resistance to chemotherapy.Nature2023https://conductscience.org/library/papers/36949199PubMed
1131257175EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis.Dev Cell2019https://conductscience.org/library/papers/31257175PubMed
1237059070Pancreatic cancer: Advances and challenges.Cell2023https://conductscience.org/library/papers/37059070PubMed
1334244439The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34244439PubMed
1433142117Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer.Cell2020https://conductscience.org/library/papers/33142117PubMed
1532302552Nitrogen Metabolism in Cancer and Immunity.Trends Cell Biol2020https://conductscience.org/library/papers/32302552PubMed
1634117030Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition.Cancer Res2021https://conductscience.org/library/papers/34117030PubMed
1720473272The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.EMBO J2010https://conductscience.org/library/papers/20473272PubMed
1833027658Respiratory Supercomplexes Promote Mitochondrial Efficiency and Growth in Severely Hypoxic Pancreatic Cancer.Cell Rep2020https://conductscience.org/library/papers/33027658PubMed
1928671190Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism.Nat Commun2017https://conductscience.org/library/papers/28671190PubMed
2022101433Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.Nature2011https://conductscience.org/library/papers/22101433PubMed

See all 52 referencesDownload CSV of references

Cited by111

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.

PMIDTitleJournalYearIn PapersSource
42977746Hepatocyte IRE1α-XBP1s axis prevents pro-metastatic niche formation through metabolic rewiring of inflammatory monocytes.Nat Commun2026https://conductscience.org/library/papers/42977746PubMed
42962039Mitochondrial metabolic reprogramming by a glutamine antagonist radioenhancer conjugate drives pyroptosis and antitumor immunity.Sci Adv2026https://conductscience.org/library/papers/42962039PubMed
42914976Cell-state-specific metabolic networks govern ferroptosis versus apoptosis in small cell lung cancer.Cell2026https://conductscience.org/library/papers/42914976PubMed
42846986Radiotherapy followed by metformin neoadjuvant therapy drives superior pancreatic cancer ferroptosis and augments anti-tumor immunity.Fundam Res2026https://conductscience.org/library/papers/42846986PubMed
42834042Glutamine metabolism in health and disease.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42834042PubMed
42824134Glutamine metabolism and its roles in tumor radiotherapy by regulating DNA damage repair.Front Cell Dev Biol2026https://conductscience.org/library/papers/42824134PubMed
42812576Glutamine Metabolism in Health and Diseases.MedComm (2020)2026https://conductscience.org/library/papers/42812576PubMed
42801687High-Density Type I Collagen Promotes IFN-γ+ CD8+ T Cell Exhaustion via SAT1-ASS1-Mediated Glutamine Accumulation and Ferroptosis in Triple-Negative Breast Cancer.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42801687PubMed
42778596Hepatocytes promote liver metastasis of pancreatic cancer by providing serine.Nature2026https://conductscience.org/library/papers/42778596PubMed
42757482A four‑gene signature identifies TKI‑induced persister cells and uncovers a ZLN005‑induced pyroptotic vulnerability via the GSDME pathway in EGFR‑mutant lung cancer.Mol Med Rep2026https://conductscience.org/library/papers/42757482PubMed
42729867Metabolic reprogramming and immune evasion interaction in the tumor microenvironment promote tumor progression.Front Oncol2026https://conductscience.org/library/papers/42729867PubMed
42729077Multi-omics integration identifies HSPA4 as a therapeutic target and reveals DON-induced endoplasmic reticulum stress in bladder cancer.Transl Androl Urol2026https://conductscience.org/library/papers/42729077PubMed
42703620KRAS-driven cytokine-metabolic crosstalk shapes immune exclusion in pancreatic ductal adenocarcinoma.Front Genet2026https://conductscience.org/library/papers/42703620PubMed
42700331Recent advancements in NRF2-regulated ferroptosis modulation for targeted cancer therapy.Mol Biol Rep2026https://conductscience.org/library/papers/42700331PubMed
42642776Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation.Exp Hematol Oncol2026https://conductscience.org/library/papers/42642776PubMed
42602712Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer.iScience2026https://conductscience.org/library/papers/42602712PubMed
42565215The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting.Biochem Soc Trans2026https://conductscience.org/library/papers/42565215PubMed
42561948Glutamine-restricted diets restore sensitivity to KRASG12D inhibitor through the reversal of ANXA1 mediated metabolic reprogramming.Cell Rep Med2026https://conductscience.org/library/papers/42561948PubMed
4251492870 Years of DON and Beyond: Glutaminase Inhibition as a Synergistic Strategy in Cancer Combination Therapy.Pharmaceutics2026https://conductscience.org/library/papers/42514928PubMed
42507221Rewiring glucose metabolism in pancreatic cancer by natural compounds: implications for immune evasion and therapeutic targets.Mol Biol Rep2026https://conductscience.org/library/papers/42507221PubMed

See all 111 cited byDownload CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACTA158PubTator's text mininghttps://conductscience.org/library/genes/58NCBI Gene
ATN11822PubTator's text mininghttps://conductscience.org/library/genes/1822NCBI Gene
AXL558PubTator's text mininghttps://conductscience.org/library/genes/558NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
DUSP61848PubTator's text mininghttps://conductscience.org/library/genes/1848NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EIF2A83939PubTator's text mininghttps://conductscience.org/library/genes/83939NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
GLS2744PubTator's text mininghttps://conductscience.org/library/genes/2744NCBI Gene
GLUL2752PubTator's text mininghttps://conductscience.org/library/genes/2752NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK35595PubTator's text mininghttps://conductscience.org/library/genes/5595NCBI Gene
PDGFRB5159PubTator's text mininghttps://conductscience.org/library/genes/5159NCBI Gene
PDPN10630PubTator's text mininghttps://conductscience.org/library/genes/10630NCBI Gene
PFAS5198PubTator's text mininghttps://conductscience.org/library/genes/5198NCBI Gene
PTF1A256297PubTator's text mininghttps://conductscience.org/library/genes/256297NCBI Gene

Download CSV of genes

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
ATEZOLIZUMABCHEMBL3707227Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3707227ChEMBL
SIRPIGLENASTATCHEMBL4650367Derived from the trial1https://conductscience.org/library/drugs/CHEMBL4650367ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37814010

GET https://conductscience.org/api/papers/v1/37814010/references?page=2